학술논문
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
Document Type
Article
Author
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, 1 January 2018, 67(1):25-38)
Subject
Language
English
ISSN
14320851
03407004
03407004